138 related articles for article (PubMed ID: 27156840)
21. Hes1, an important gene for activation of hepatic stellate cells, is regulated by Notch1 and TGF-β/BMP signaling.
Zhang K; Zhang YQ; Ai WB; Hu QT; Zhang QJ; Wan LY; Wang XL; Liu CB; Wu JF
World J Gastroenterol; 2015 Jan; 21(3):878-87. PubMed ID: 25624721
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of MiR-93 expression reduces cell proliferation and clonogenicity of HepG2 cells.
Xu D; He XX; Chang Y; Sun SZ; Xu CR; Lin JS
Hepatogastroenterology; 2012; 59(120):2367-73. PubMed ID: 22773266
[TBL] [Abstract][Full Text] [Related]
23. Mutation rates of TGFBR2 and ACVR2 coding microsatellites in human cells with defective DNA mismatch repair.
Chung H; Young DJ; Lopez CG; Le TA; Lee JK; Ream-Robinson D; Huang SC; Carethers JM
PLoS One; 2008; 3(10):e3463. PubMed ID: 18941508
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor beta stimulation of colorectal cancer cell lines: type II receptor bypass and changes in adhesion molecule expression.
Ilyas M; Efstathiou JA; Straub J; Kim HC; Bodmer WF
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3087-91. PubMed ID: 10077641
[TBL] [Abstract][Full Text] [Related]
25. Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers.
Hempen PM; Zhang L; Bansal RK; Iacobuzio-Donahue CA; Murphy KM; Maitra A; Vogelstein B; Whitehead RH; Markowitz SD; Willson JK; Yeo CJ; Hruban RH; Kern SE
Cancer Res; 2003 Mar; 63(5):994-9. PubMed ID: 12615714
[TBL] [Abstract][Full Text] [Related]
26. RIS1, a gene with trinucleotide repeats, is a target in the mutator pathway of colorectal carcinogenesis.
Iglesias D; Fernández-Peralta AM; Nejda N; Daimiel L; Azcoita MM; Oliart S; González-Aguilera JJ
Cancer Genet Cytogenet; 2006 Jun; 167(2):138-44. PubMed ID: 16737913
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-200b stimulates tumour growth in TGFBR2-null colorectal cancers by negatively regulating p27/kip1.
Fu Y; Liu X; Zhou N; Du L; Sun Y; Zhang X; Ge Y
J Cell Physiol; 2014 Jun; 229(6):772-82. PubMed ID: 24151081
[TBL] [Abstract][Full Text] [Related]
28. Tgf-beta signaling alterations and colon cancer.
Bellam N; Pasche B
Cancer Treat Res; 2010; 155():85-103. PubMed ID: 20517689
[TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
[TBL] [Abstract][Full Text] [Related]
30. Microsatellite unstable colorectal cancer cell lines with truncating TGFbetaRII mutations remain sensitive to endogenous TGFbeta.
Baker K; Raut P; Jass JR
J Pathol; 2007 Nov; 213(3):257-65. PubMed ID: 17893910
[TBL] [Abstract][Full Text] [Related]
31. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
32. Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers.
Yamashita S; Takahashi S; McDonell N; Watanabe N; Niwa T; Hosoya K; Tsujino Y; Shirai T; Ushijima T
Cancer Res; 2008 Apr; 68(7):2112-21. PubMed ID: 18381416
[TBL] [Abstract][Full Text] [Related]
33. Somatic acquisition and signaling of TGFBR1*6A in cancer.
Pasche B; Knobloch TJ; Bian Y; Liu J; Phukan S; Rosman D; Kaklamani V; Baddi L; Siddiqui FS; Frankel W; Prior TW; Schuller DE; Agrawal A; Lang J; Dolan ME; Vokes EE; Lane WS; Huang CC; Caldes T; Di Cristofano A; Hampel H; Nilsson I; von Heijne G; Fodde R; Murty VV; de la Chapelle A; Weghorst CM
JAMA; 2005 Oct; 294(13):1634-46. PubMed ID: 16204663
[TBL] [Abstract][Full Text] [Related]
34. Two types of sporadic multiple colorectal cancers with and without HNPCC-like genetic instability.
Komura K; Masuda H; Esumi M
Hepatogastroenterology; 1999; 46(30):3115-20. PubMed ID: 10626171
[TBL] [Abstract][Full Text] [Related]
35. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
Shin KH; Park YJ; Park JG
Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
[TBL] [Abstract][Full Text] [Related]
36. Joint TGF-β type II receptor-expressing cells: ontogeny and characterization as joint progenitors.
Li T; Longobardi L; Myers TJ; Temple JD; Chandler RL; Ozkan H; Contaldo C; Spagnoli A
Stem Cells Dev; 2013 May; 22(9):1342-59. PubMed ID: 23231014
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-20b promotes cell proliferation via targeting of TGF-β receptor II and upregulates MYC expression in Ewing's sarcoma cells.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
Int J Oncol; 2017 Dec; 51(6):1842-1850. PubMed ID: 29039480
[TBL] [Abstract][Full Text] [Related]
38. N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.
Holst S; Deuss AJ; van Pelt GW; van Vliet SJ; Garcia-Vallejo JJ; Koeleman CA; Deelder AM; Mesker WE; Tollenaar RA; Rombouts Y; Wuhrer M
Mol Cell Proteomics; 2016 Jan; 15(1):124-40. PubMed ID: 26537799
[TBL] [Abstract][Full Text] [Related]
39. Concordant promoter methylation of transforming growth factor-beta receptor types I and II occurs early in esophageal squamous cell carcinoma.
Dong Z; Guo W; Guo Y; Kuang G; Yang Z
Am J Med Sci; 2012 May; 343(5):375-81. PubMed ID: 22314103
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1.
Xu X; Chen R; Li Z; Huang N; Wu X; Li S; Li Y; Wu S
BMC Cancer; 2015 Dec; 15():1023. PubMed ID: 26714817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
